123 related articles for article (PubMed ID: 21358315)
1. Angiotensin II upregulation of cardiomyocyte adiponectin production is nitric oxide/cyclic GMP dependent.
Guo B; Li Y; Han R; Zhou H; Wang M
Am J Med Sci; 2011 May; 341(5):350-5. PubMed ID: 21358315
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
Straubinger J; Schöttle V; Bork N; Subramanian H; Dünnes S; Russwurm M; Gawaz M; Friebe A; Nemer M; Nikolaev VO; Lukowski R
J Pharmacol Exp Ther; 2015 Sep; 354(3):406-16. PubMed ID: 26157043
[TBL] [Abstract][Full Text] [Related]
4. Neuronal nitric oxide synthase is up-regulated by angiotensin II and attenuates NADPH oxidase activity and facilitates relaxation in murine left ventricular myocytes.
Jin CZ; Jang JH; Wang Y; Kim JG; Bae YM; Shi J; Che CR; Kim SJ; Zhang YH
J Mol Cell Cardiol; 2012 Jun; 52(6):1274-81. PubMed ID: 22484619
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.
Kim D; Aizawa T; Wei H; Pi X; Rybalkin SD; Berk BC; Yan C
J Mol Cell Cardiol; 2005 Jan; 38(1):175-84. PubMed ID: 15623434
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells.
Gendron L; Côté F; Payet MD; Gallo-Payet N
Neuroendocrinology; 2002 Jan; 75(1):70-81. PubMed ID: 11810036
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
8. [Effect of protein kinase C on inhibition of nitric oxide synthesis in cultured neonatal rat cardiomyocytes by angiotensin II].
Fu SG; Liu PQ; Lu W; Gong SZ; Pan JY
Sheng Li Xue Bao; 2000 Aug; 52(4):318-22. PubMed ID: 11951115
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts.
Wei Y; Wang W
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F175-81. PubMed ID: 12388389
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
Chang L; Yang R; Wang M; Liu J; Wang Y; Zhang H; Li Y
Am J Med Sci; 2012 Mar; 343(3):220-6. PubMed ID: 21841463
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
13. ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes.
Jang JH; Chun JN; Godo S; Wu G; Shimokawa H; Jin CZ; Jeon JH; Kim SJ; Jin ZH; Zhang YH
Basic Res Cardiol; 2015 May; 110(3):21. PubMed ID: 25804308
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
[TBL] [Abstract][Full Text] [Related]
15. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
Chaki S; Inagami T
Mol Pharmacol; 1993 Apr; 43(4):603-8. PubMed ID: 7682650
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II].
Liu PQ; Lu W; Pan JY
Sheng Li Xue Bao; 2002 Jun; 54(3):213-8. PubMed ID: 12075467
[TBL] [Abstract][Full Text] [Related]
17. Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.
Meng G; Yang S; Chen Y; Yao W; Zhu H; Zhang W
Pharm Biol; 2015 Jun; 53(6):904-12. PubMed ID: 25471017
[TBL] [Abstract][Full Text] [Related]
18. Propofol depresses angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Cheng TH; Leung YM; Cheung CW; Chen CH; Chen YL; Wong KL
Anesthesiology; 2010 Jan; 112(1):108-18. PubMed ID: 20032702
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic Ca2+-induced apoptosis in rat cardiomyocytes via mitochondrial NO-cGMP-protein kinase G pathway.
Seya K; Ono K; Fujisawa S; Okumura K; Motomura S; Furukawa K
J Pharmacol Exp Ther; 2013 Jan; 344(1):77-84. PubMed ID: 23104881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
